The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stock Elyse since 2019.
This trader's CIK number is 1785732.
At the time of last reporting, Stock Elyse was the Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd.. (stock ticker symbol BHVN).
Also see all insider trading activities at Biohaven Pharmaceutical Holding Co Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | BHVN | 0 | $0 | 0 | $0 | 10,187 | $0 |
| 2021 | BHVN | 0 | $0 | 28,858 | $3,047,791 | 37,233 | $456,099 |
| 2020 | BHVN | 0 | $0 | 36,966 | $2,382,089 | 41,278 | $1,035,867 |
| 2019 | BHVN | 0 | $0 | 18,500 | $833,764 | 21,875 | $200,170 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-01-10 | BHVN | Option Ex | 937 | .00 | 0 |
| 2022-01-06 | BHVN | Option Ex | 5,000 | .00 | 0 |
| 2022-01-07 | BHVN | Option Ex | 4,250 | .00 | 0 |
| 2021-12-14 | BHVN | Option Ex | 6,939 | 15.80 | 109,670 |
| 2021-12-15 | BHVN | Option Ex | 21,919 | 15.80 | 346,429 |
| 2021-12-14 | BHVN | Sale | 6,939 | 105.02 | 728,761 |
| 2021-12-15 | BHVN | Sale | 21,919 | 105.80 | 2,319,030 |
| 2021-11-25 | BHVN | Option Ex | 3,375 | .00 | 0 |
| 2021-01-06 | BHVN | Option Ex | 5,000 | .00 | 0 |
| 2020-11-25 | BHVN | Option Ex | 3,375 | .00 | 0 |
| 2020-06-12 | BHVN | Option Ex | 36,966 | 26.61 | 983,480 |
| 2020-06-12 | BHVN | Sale | 36,966 | 64.44 | 2,382,089 |
| 2020-01-08 | BHVN | Option Ex | 937 | 55.91 | 52,387 |
| 2019-12-18 | BHVN | Option Ex | 3,375 | .00 | 0 |
| 2019-10-18 | BHVN | Option Ex | 17,700 | 10.82 | 191,514 |
| 2019-10-18 | BHVN | Sale | 17,700 | 45.07 | 797,756 |
| 2019-10-15 | BHVN | Option Ex | 800 | 10.82 | 8,656 |
| 2019-10-15 | BHVN | Sale | 800 | 45.01 | 36,008 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stock Elyse (Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.